The Life Sciences Strategy Summit on IP and Exclusivity

The Life Sciences Strategy Summit on IP and Exclusivity addresses the evolving landscape of intellectual property, exclusivity, and legal frameworks in the life sciences sector.

Topics

• Data exclusivity and clinical trial regulations
• Patentability and opposition proceedings
• Transactions and M&A in life sciences
• SPC and PTE developments
• Divisional patenting strategies
• Patent quality and enforcement
• Second medical uses and preliminary injunctions
• Artificial intelligence in regulatory frameworks
• Unified Patent Court implications

Who should Attend

• Patent attorneys
• In-house counsel
• Biotech industry professionals
• Legal experts in IP and exclusivity
• Industry executives
• Pharmaceutical company representatives
• Regulatory affairs specialists
• Policy makers
• R&D leaders
• Officials from patent offices